ClinicalTrials.Veeva

Menu

Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer (CROSS-1)

N

National Cancer Institute, Naples

Status

Enrolling

Conditions

Metastatic Colorectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01651026
CROSS-1

Details and patient eligibility

About

The purpose of this study is to describe the diagnostic and treatment procedures employed for patients with rectal cancer in each participating center. Outcomes to treatment, costs of treatment will be described. Exploratory analyses will be done to identify factor that influence patient prognosis, as well as factors that predict patient response to treatment.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologic diagnosis rectal carcinoma
  • Signed informed consent

Exclusion criteria

  • Refusal or incapability of providing informed consent

Trial design

600 participants in 1 patient group

rectal cancer

Trial contacts and locations

3

Loading...

Central trial contact

Marilina Piccirillo, M.D.; Francesco Perrone, M.D., Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems